Pathstone Family Office’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-842
| Closed | -$131K | – | 1451 |
|
|
2020
Q4 | $131K | Buy |
842
+755
| +868% | +$117K | 0.01% | 336 |
|
|
2020
Q3 | $10K | Hold |
87
| – | – | ﹤0.01% | 607 |
|
|
2020
Q2 | $10K | Sell |
87
-230
| -73% | -$26.4K | ﹤0.01% | 526 |
|
|
2020
Q1 | $29K | Buy |
317
+87
| +38% | +$7.96K | ﹤0.01% | 379 |
|
|
2019
Q4 | $249K | Hold |
230
| – | – | ﹤0.01% | 388 |
|
|
2019
Q3 | $23K | Hold |
230
| – | – | ﹤0.01% | 376 |
|
|
2019
Q2 | $30K | Hold |
230
| – | – | ﹤0.01% | 399 |
|
|
2019
Q1 | $31K | Buy |
+230
| New | +$31K | ﹤0.01% | 373 |
|
|
2017
Q2 | – | Sell |
-12
| Closed | -$1K | – | 687 |
|
|
2017
Q1 | $1K | Buy |
+12
| New | +$1K | ﹤0.01% | 547 |
|
|
2013
Q3 | – | Sell |
-23
| Closed | -$2K | – | 459 |
|
|
2013
Q2 | $2K | Buy |
+23
| New | +$2K | ﹤0.01% | 346 |
|